Review pipeline by customer fit, observable stage progress, deal age and the buyer's unresolved question. Separate active opportunities from hopeful records. The diagnostic should identify the most important break in progression and the evidence needed to decide whether the fix belongs in acquisition, sales, proof or the offer itself.
A large pipeline can still be a weak one
The CRM contains a substantial potential revenue number. Yet few opportunities move, close dates shift and the founder struggles to explain which deals are real.
Pipeline value depends on the quality of the records and the evidence behind their stages. A contact who enjoyed a demo is not automatically an opportunity with an active buying process.
Start by inspecting a manageable group of recent, stalled and successful deals. You need enough variety to compare the process, not a perfect dashboard before asking useful questions.
Check fit before stage
For each opportunity, record the customer's problem, relevant fit conditions and why the product can help. Mark assumptions the team has not confirmed.
An attractive logo can remain a weak opportunity if the need is speculative or the product requires conditions the buyer does not have. Do not let deal size substitute for qualification.
Compare the opportunity with customers who actually succeed. This connects pipeline quality to the working ICP rather than only to a target-account list.
Require evidence of progression
Define stages through observable buyer and seller actions. Examples might include a confirmed problem, a relevant stakeholder joining the discussion, an agreed evaluation or a documented commercial review.
Avoid stages based only on seller activity. Sending a proposal proves that the company sent a proposal. It does not prove that the buyer is evaluating it or has an agreed decision process.
Record the next meaningful step and who owns it. An opportunity without a plausible next step deserves review rather than automatic inclusion in a forecast.
Inspect age and unanswered questions
Look at how long deals spend in each stage, while accounting for segment and deal complexity. A longer cycle may be normal for a different type of customer. It may also reveal friction that the team has normalised.
For each stalled deal, write the last important unresolved question. Implementation, security, internal value, switching effort and budget approval lead to different next actions.
“Following up” is an activity. The question is what the follow-up needs to resolve.
Compare wins, losses and no decisions
Review why customers bought, chose another option or did nothing. Keep no-decision outcomes visible; they can reveal weak urgency or an incomplete internal case rather than competitive defeat.
Look for repeated patterns, then check the interpretation with sales notes or direct feedback. Do not force every loss into a standard reason because the CRM requires a dropdown choice.
Choose the next repair
If many opportunities lack fit, refine targeting and qualification. If they share one unresolved risk, build the evidence or implementation answer. If the team cannot identify a buying process, improve discovery and stakeholder understanding.
Some problems require product or commercial changes. Marketing should make the constraint visible rather than disguising it with more assets.
Make the review repeatable
Keep stage definitions, required evidence and feedback visible to the team. Review the resulting changes after enough opportunities have progressed to teach you something.
First 10's Diagnostic examines the funnel alongside message and channel evidence. The useful output is a priority the company can act on, with a clearer distinction between active demand and a pipeline number built from hope.
Apply this to your business
Review five stalled deals and record the buyer's latest unanswered question, stakeholder and next commitment. Group the stalls before prescribing a channel fix.
Frequently asked questions
What is the difference between pipeline volume and pipeline health?
Volume describes how much is recorded. Health depends on fit, stage evidence, age, value and a credible next step. Large totals can hide stalled or unsuitable opportunities.
How can a small startup diagnose its pipeline?
Review a manageable set of recent wins, losses and stalled deals. Use consistent stage definitions and inspect what changed at each step rather than relying only on a dashboard total.
Pipeline looks full but revenue lags?
Bring recent won, lost and stalled deals. Mohit can map the common break in buyer progression.
Talk through the problem ↗See how we could work together
